NCT00899405
Recruiting
Not Applicable
EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
University of California, Davis1 site in 1 country800 target enrollmentStarted: May 2005Last updated:
ConditionsLung Cancer
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 800
- Locations
- 1
- Primary Endpoint
- Mutational status of the EGFR pathway
Overview
Brief Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
Detailed Description
OBJECTIVES:
- Examine the mutational status of the EGFR pathway in tumor and blood samples from patients with lung cancer.
- Correlate the EGFR pathway mutations in these samples with clinical outcomes of these patients.
OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway mutations in DNA.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Mutational status of the EGFR pathway
Time Frame: up to 1 year
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)Non Small Cell Lung CancerEGFR-TKI Resistant MutationEGFR-TKI Sensitizing MutationNCT02661009GenoSaber1,000
Withdrawn
Not Applicable
Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507Lung CancerNCT00907699Case Comprehensive Cancer Center
Completed
Not Applicable
Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung CancerLung CancerNCT00898924Alliance for Clinical Trials in Oncology60
Completed
Not Applicable
Monitoring study of genomic mutations in patients with EGFR mutation or ALK translocation using plasma DNAnon-small-cell lung cancerJPRN-UMIN000035628Wakayama Medical University100
Recruiting
Not Applicable
DNA Analysis of Blood and Tissue from Patients with Lung CancerLung CancerNCT00471978Massachusetts General Hospital6,800